The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,881 followers.

New Research: The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB https://t.co/3ziO92HP0r #pharmacology

24 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.